货号:GS40555
Polatuzumab vedotin (commercial name Polivy®) is an antibody-drug conjugate (ADC) designed for targeted cancer therapy. It consists of a humanized anti-CD79b monoclonal antibody (polatuzumab) covalently linked to a potent cytotoxic agent, monomethyl auristatin E (MMAE), via a cleavable linker. The antibody component specifically delivers the cytotoxic payload to B-cells expressing the target protein.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
周璐